Ivarmacitinib for Refractory Behcet's Syndrome
NCT07634848
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Plans to rejoin a center
Conditions
Behcet's Syndrome
Interventions
DRUG:
Ivarmacitinib
Sponsor
Liu Tian